Endo International PLC Rating Increased to Overweight at Morgan Stanley (ENDP)
Endo International PLC (NASDAQ:ENDP) was upgraded by equities researchers at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research report issued on Friday, AnalystRatings.NET reports. The firm currently has a $79.00 price objective on the stock. Morgan Stanley’s price objective indicates a potential upside of 19.05% from the stock’s previous close.
The analysts wrote, “Mesh settlement removes what had been a potential multi-billion dollar liability in our bear case, and we now see a compelling risk-reward driven by M&A upside in our bull case. Our $79 PT assumes mgmt. follows through on 2-3 deals over the near-term.”
Other equities research analysts have also recently issued reports about the stock. Analysts at National Alliance Securities initiated coverage on shares of Endo International PLC in a research note on Wednesday. They set a “buy” rating and a $76.00 price target on the stock. Separately, analysts at Cantor Fitzgerald cut their price target on shares of Endo International PLC from $43.00 to $36.00 in a research note on Thursday, April 24th. They now have a “sell” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Endo International PLC in a research note on Thursday, April 17th. They now have a $61.00 price target on the stock. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $62.32.
Endo International PLC (NASDAQ:ENDP) traded up 0.86% during mid-day trading on Friday, hitting $66.93. 1,347,690 shares of the company’s stock traded hands. Endo International PLC has a 52 week low of $32.66 and a 52 week high of $82.16. The stock’s 50-day moving average is $64.90 and its 200-day moving average is $64.6. The company’s market cap is $7.739 billion. Endo International PLC also was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 8,404,349 shares, a decrease of 16.1% from the March 31st total of 10,011,391 shares. Based on an average trading volume of 4,078,228 shares, the short-interest ratio is currently 2.1 days. Currently, 5.8% of the company’s stock are short sold.
Endo International PLC (NASDAQ:ENDP) last released its earnings data on Thursday, May 1st. The company reported $0.92 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.84 by $0.08. The company had revenue of $595.00 million for the quarter, compared to the consensus estimate of $608.86 million. During the same quarter in the prior year, the company posted $1.09 earnings per share. The company’s quarterly revenue was down 9.3% on a year-over-year basis. Analysts expect that Endo International PLC will post $3.57 EPS for the current fiscal year.
Endo International PLC, formerly Endo Health Solutions Inc, incorporated on November 18, 1997, is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.